Galmed Pharmaceuticals Ltd (GLMD)

Jan 07, 2026

What drives Galmed Pharmaceuticals Ltd GPH stock priceTrade Execution Strategies & Small Capital Investment Tips - earlytimes.in

Jan 07, 2026

Jan 01, 2026

EBIT per share of Galmed Pharmaceuticals Ltd. – BER:GPH - TradingView — Track All Markets

Jan 01, 2026

Dec 29, 2025

Will Galmed Pharmaceuticals Ltd. stock outperform tech sector in 2025Market Sentiment Surveys & Free Rapid Wealth Multiplication - bollywoodhelpline.com

Dec 29, 2025

Dec 28, 2025

Is Galmed Pharmaceuticals Ltd. stock a defensive play in 2025Evening Star Patterns & High Profit Market Ideas - bollywoodhelpline.com

Dec 28, 2025

Dec 25, 2025

Downgrade Watch: Why Galmed Pharmaceuticals Ltd stock is seen as undervalued2025 Short Interest & Weekly Breakout Stock Alerts - moha.gov.vn

Dec 25, 2025

Dec 22, 2025

Financial Survey: Galmed Pharmaceuticals (NASDAQ:GLMD) vs. Qualigen Therapeutics (NASDAQ:QLGN) - Defense World

Dec 22, 2025

Dec 21, 2025

Will Galmed Pharmaceuticals Ltd. stock benefit from upcoming earnings reportsJuly 2025 Review & Low Drawdown Investment Strategies - Улправда

Dec 21, 2025

Dec 20, 2025

Aug Selloffs: How interest rate cuts could boost Galmed Pharmaceuticals Ltd. stock2025 Key Lessons & Long-Term Growth Portfolio Plans - Улправда

Dec 20, 2025

Dec 20, 2025

How interest rate cuts could boost Galmed Pharmaceuticals Ltd. stock2025 Price Action Summary & Daily Stock Trend Watchlist - Улправда

Dec 20, 2025

Dec 20, 2025

Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Passes Below Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 20, 2025

Dec 20, 2025

How big funds are accumulating Galmed Pharmaceuticals Ltd. (GPH) stockMarket Capitalization Trends & Outperform the Market with Aggressive Picks - Bollywood Helpline

Dec 20, 2025

Dec 19, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock a safe buy pre earningsMarket Trend Review & Weekly Top Gainers Trade List - DonanımHaber

Dec 19, 2025

Dec 08, 2025

Galmed to present data on Aramchol’s potential in liver cancer By Investing.com - Investing.com Canada

Dec 08, 2025

Dec 08, 2025

Galmed to present data on Aramchol’s potential in liver cancer - Investing.com

Dec 08, 2025

Dec 08, 2025

Galmed Pharmaceuticals’ Aramchol Abstract Accepted for HEP-DART 2025 Presentation - TipRanks

Dec 08, 2025

Dec 08, 2025

Galmed Pharmaceuticals’ Aramchol abstract accepted for HEP-DART 2025 presentation - MSN

Dec 08, 2025

Dec 08, 2025

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting - PR Newswire

Dec 08, 2025

Dec 05, 2025

Galmed receives patent for combination therapy in South Korea By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock surprise with quarterly resultsBuy Signal & Weekly Breakout Watchlists - Newser

Dec 05, 2025

Dec 04, 2025

Galmed Announces Grant of New Use Patents for the Combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra for Mash - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Galmed stock rises after patent grant for MASH combo therapy By Investing.com - Investing.com Nigeria

Dec 04, 2025

Dec 04, 2025

Galmed stock rises after patent grant for MASH combo therapy - Investing.com

Dec 04, 2025

Dec 04, 2025

Galmed receives patent for combination therapy in South Korea - Investing.com

Dec 04, 2025

Dec 04, 2025

Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy - TipRanks

Dec 04, 2025

Dec 04, 2025

Galmed announces grant of new use patents for the combination of Aramchol and Madrigal Pharmaceuticals - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH - PR Newswire

Dec 04, 2025

Dec 04, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock sustain free cash flowQuarterly Trade Review & Accurate Trade Setup Notifications - Newser

Dec 04, 2025

Dec 04, 2025

Galmed Pharmaceuticals (NASDAQ:GLMD) Stock Passes Below 200-Day Moving Average – Should You Sell? - Defense World

Dec 04, 2025

Dec 04, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock supported by strong fundamentals2025 EndofYear Setup & Risk Managed Investment Signals - Newser

Dec 04, 2025

Dec 03, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock good for long term investing - Newser

Dec 03, 2025

Dec 03, 2025

Can Galmed Pharmaceuticals Ltd. (GPH) stock attract ESG investmentsTrade Volume Summary & High Accuracy Investment Signals - Newser

Dec 03, 2025

Dec 02, 2025

Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN

Dec 02, 2025

Dec 02, 2025

Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position - MSN

Dec 02, 2025

Dec 02, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock positioned for digital growth era2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser

Dec 02, 2025

Dec 01, 2025

Galmed reports $19.2 million cash position, advances Aramchol programs By Investing.com - Investing.com Nigeria

Dec 01, 2025

Dec 01, 2025

Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook By Investing.com - Investing.com Nigeria

Dec 01, 2025

Dec 01, 2025

Galmed Pharmaceuticals stock rises on CEO’s optimistic outlook - Investing.com

Dec 01, 2025